For the Inventor, By the Inventor

Enter assignee name

Eastgate Village, Eastgate Little Island, Co Cork, Ireland

Tibotec Pharmaceuticals Ltd.

USPTO Granted Patents = 67

CIPO Patents = 23

EPO Patents = 35

Trademarks = 3

Forward Citations = 273

Loading Chart...

Loading Chart...

142 inventors (with patents filed for the assignee):

Herman Augustinus De Kock (19 out of 36 patents)

Dominique Louis Nestor Ghislain Surleraux (18 out of 32 patents)

Abdellah Tahri (13 out of 61 patents)

4. Pierre Jean-Marie Bernard Raboisson (13 out of 178 patents)

5. Piet Tom Bert Paul Wigerinck (12 out of 24 patents)

6. Sandrine Marie Helene Vendeville (11 out of 41 patents)

7. Kenneth Simmen (10 out of 26 patents)

8. Marie-Pierre T M M G De Bethune (8 out of 10 patents)

9. Bart Rudolf Romanie Kesteleyn (7 out of 36 patents)

10. Jean-François Bonfanti (6 out of 44 patents)

11. Wim Gaston Verschueren (6 out of 32 patents)

12. Jerôme Emile Georges Guillemont (6 out of 27 patents)

13. Åsa Annica Kristina Rosenquist (6 out of 18 patents)

14. Karl Magnus Nilsson (6 out of 18 patents)

15. Lili Hu (5 out of 37 patents)

Core Competencies:

HIV Protease Inhibitors

Hepatitis C Virus Inhibitors

Macrocyclic Compounds

Pyrimidine Derivatives

Benzimidazole Compounds

Phenotypic Drug Resistance

Viral Replication Inhibitors

Aminophenylsulfonamide Derivatives

Microbicidal Agents

Polymorphic Forms

Fused Bicyclic Inhibitors

Anti-Infective Pharmaceutical Agents

67 patents: Sort by Forward Citations

1. 8916558 - Powders for reconstitution (2014-12-23),

2. 8618291 - Process for preparing 4-[(1,6-dihydro-6-OXO-2-pyrimidinyl)amino]benzonitrile (2013-12-31),

3. 8575342 - HIV inhibiting 5-heterocyclyl pyrimidines (2013-11-05),

4. 8546076 - Mutational profile in HIV-1 GAG cleavage site correlated with phenotypic drug resistance (2013-10-01),

5. 8426434 - Crystalline form of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile (2013-04-23),

6. 8357687 - Macrocyclic indole derivatives useful as hepatitis C virus inhibitors (2013-01-22),

7. 8349869 - Macrocylic inhibitors of hepatitis C virus (2013-01-08),

8. 8285666 - Phenotype prediction method (2012-10-09),

9. 8183394 - Protease inhibitor precursor synthesis (2012-05-22),

10. 8183277 - Macrocylic inhibitors of hepatitis C virus (2012-05-22),

11. 8178694 - Heterocyclylaminoalkyl substituted benzimidazoles (2012-05-15),

12. 8163745 - HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines (2012-04-24),

13. 8153800 - Macrocyclic inhibitors of hepatitis C virus (2012-04-10),

14. 8153640 - HIV inhibiting bicyclic pyrimdine derivatives (2012-04-10),

15. 8148399 - Macrocyclic inhibitors of hepatitis C virus (2012-04-03),

Tibotec Pharmaceuticals Ltd. is a global pharmaceutical company dedicated to developing innovative treatments for HIV/AIDS and other infectious diseases. Our mission is to improve the health and quality of life of people living with these diseases. We focus on research, development, and commercialization of antiretroviral drugs and therapies. With a strong commitment to scientific excellence, we collaborate with partners worldwide to advance medical breakthroughs in the fight against HIV/AIDS and related infections.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

67 Patents

#1 in Eastgate Village, Eastgate Little Island, Co Cork

#44 in Ireland

#10,741 in the World

Eastgate Village, Eastgate Little Island, Co Cork, Ireland

Tibotec Pharmaceuticals Ltd.

Forward Citations = 273

142 inventors:

Herman Augustinus De Kock (19 out of 36 patents)

Dominique Louis Nestor Ghislain Surleraux (18 out of 32 patents)

Abdellah Tahri (13 out of 61 patents)

4. Pierre Jean-Marie Bernard Raboisson (13 out of 178 patents)

5. Piet Tom Bert Paul Wigerinck (12 out of 24 patents)

Please report any incorrect information to support@idiyas.com

Loading…